
Blueprint Medicines Corporation BPMC
Quartalsbericht 2025-Q1
hinzugefügt 01.05.2025
Blueprint Medicines Corporation P/E 2011-2026 | BPMC
P/E Jährlich Blueprint Medicines Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -88.8 | -10.5 | -4.76 | -9.73 | 19.5 | -8.84 | -13.1 | -20.7 | -12.6 | -5.43 | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 19.5 | -88.8 | -15.5 |
P/E anderer Aktien in der Pharmaeinzelhändler
| Name | P/E | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-0.612 | - | 2.43 % | $ 254 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-66.5 | $ 3.33 | 0.91 % | $ 8.01 B | ||
|
ARCA biopharma
ABIO
|
-5.78 | - | 1052.0 % | $ 415 M | ||
|
Aurinia Pharmaceuticals
AUPH
|
8.83 | $ 14.11 | -3.13 % | $ 1.9 B | ||
|
Aeterna Zentaris
AEZS
|
-4.94 | - | 5.93 % | $ 314 M | ||
|
Albireo Pharma
ALBO
|
-15.8 | - | -0.23 % | $ 916 M | ||
|
I-Mab
IMAB
|
-0.236 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
55.7 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
2.49 K | - | 2.54 % | $ 160 B | ||
|
Aileron Therapeutics
ALRN
|
-0.608 | - | 10.36 % | $ 9.8 M | ||
|
BioVie
BIVI
|
-0.139 | $ 1.29 | -3.31 % | $ 1.91 M | ||
|
Biophytis SA
BPTS
|
-17.6 | - | -13.47 % | $ 169 M | ||
|
Ascendis Pharma A/S
ASND
|
-19.2 | $ 216.01 | -0.94 % | $ 5 B | ||
|
BioNTech SE
BNTX
|
6.11 | $ 86.86 | -1.75 % | $ 27.2 B | ||
|
Midatech Pharma plc
MTP
|
-14.5 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.57 | - | -1.52 % | $ 24.7 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
12.7 | $ 19.42 | 0.99 % | $ 908 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-1.71 | - | - | $ 26.5 M | ||
|
AgeX Therapeutics
AGE
|
-0.00095 | - | -10.17 % | $ 12.2 K | ||
|
Acorda Therapeutics
ACOR
|
-0.0662 | - | -24.86 % | $ 820 K | ||
|
Corbus Pharmaceuticals Holdings
CRBP
|
-1.62 | $ 8.18 | -3.02 % | $ 109 M | ||
|
Acasti Pharma
ACST
|
-4.26 | - | 4.01 % | $ 150 M | ||
|
CytomX Therapeutics
CTMX
|
-53.6 | $ 4.2 | -5.83 % | $ 579 M | ||
|
Институт стволовых клеток человека
ISKJ
|
38.8 | - | - | - | ||
|
CollPlant Biotechnologies Ltd.
CLGN
|
-1.7 | $ 0.73 | 20.26 % | $ 8.36 M | ||
|
Adverum Biotechnologies
ADVM
|
-0.583 | - | - | $ 86.2 M | ||
|
Acer Therapeutics
ACER
|
-0.463 | - | 2.71 % | $ 14 M | ||
|
Advaxis
ADXS
|
-0.0388 | - | -9.65 % | $ 45.9 M | ||
|
Eton Pharmaceuticals
ETON
|
-121 | $ 22.9 | -3.82 % | $ 616 M | ||
|
Exelixis
EXEL
|
15 | $ 41.46 | 0.12 % | $ 11.3 B | ||
|
Avenue Therapeutics
ATXI
|
-0.0465 | - | -52.27 % | $ 4.45 M | ||
|
Autolus Therapeutics plc
AUTL
|
-1.92 | $ 1.35 | -3.34 % | $ 344 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-0.203 | - | - | $ 7.46 M | ||
|
ChemoCentryx
CCXI
|
-0.0138 | - | - | $ 3.74 B | ||
|
Aytu BioScience
AYTU
|
-1.16 | $ 2.6 | -1.14 % | $ 16.3 M | ||
|
Fulcrum Therapeutics
FULC
|
-0.0072 | $ 6.64 | -3.63 % | $ 421 K | ||
|
Atreca
BCEL
|
-0.504 | - | -11.76 % | $ 5.79 M | ||
|
BioDelivery Sciences International
BDSI
|
3.63 | - | -4.8 % | $ 255 M | ||
|
Genmab A/S
GMAB
|
33.2 | $ 25.62 | -0.23 % | $ 16.4 B | ||
|
Aeglea BioTherapeutics
AGLE
|
-3.48 | - | - | $ 1.01 B | ||
|
Grifols, S.A.
GRFS
|
31.7 | $ 7.6 | -1.24 % | $ 6.83 B | ||
|
CureVac N.V.
CVAC
|
-8.58 | - | - | $ 867 M | ||
|
BeiGene, Ltd.
BGNE
|
-392 | - | 0.49 % | $ 251 B | ||
|
Halozyme Therapeutics
HALO
|
30.5 | $ 61.92 | -1.5 % | $ 7.42 B | ||
|
Bellerophon Therapeutics
BLPH
|
-3.96 | - | -74.18 % | $ 955 K | ||
|
Akero Therapeutics
AKRO
|
-12.9 | - | - | $ 3.67 B | ||
|
Immatics N.V.
IMTX
|
-5.39 | $ 9.4 | -1.16 % | $ 591 M | ||
|
Arbutus Biopharma Corporation
ABUS
|
-25.3 | $ 4.29 | -2.94 % | $ 822 M | ||
|
Incyte Corporation
INCY
|
15.1 | $ 90.93 | 0.53 % | $ 17.7 B | ||
|
Akouos
AKUS
|
-1.98 | - | 0.23 % | $ 488 M |